Compare ALNT & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALNT | VIR |
|---|---|---|
| Founded | 1962 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 903.4M | 773.5M |
| IPO Year | N/A | 2019 |
| Metric | ALNT | VIR |
|---|---|---|
| Price | $54.52 | $6.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $50.33 | $25.73 |
| AVG Volume (30 Days) | 170.0K | ★ 1.8M |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | ★ 0.22% | N/A |
| EPS Growth | ★ 28.52 | N/A |
| EPS | ★ 1.12 | N/A |
| Revenue | ★ $533,134,000.00 | $16,860,000.00 |
| Revenue This Year | $4.80 | N/A |
| Revenue Next Year | $5.42 | $48.05 |
| P/E Ratio | $48.66 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $19.25 | $4.16 |
| 52 Week High | $58.13 | $14.45 |
| Indicator | ALNT | VIR |
|---|---|---|
| Relative Strength Index (RSI) | 57.57 | 59.18 |
| Support Level | $51.90 | $5.45 |
| Resistance Level | $55.36 | $6.93 |
| Average True Range (ATR) | 2.36 | 0.45 |
| MACD | 0.20 | 0.08 |
| Stochastic Oscillator | 79.74 | 71.55 |
Allient Inc, formerly Allied Motion Technologies Inc designs, manufactures, and sells precision and specialty motion control components and systems. The firm primarily caters to the vehicle, medical, aerospace and defense, and electronics and industrial, pumps, and robotics sectors. It mainly operates and sells across the United States, Canada, South America, Europe, and Asia. Its products and solutions include nano precision positioning systems, servo control systems, motion controllers, digital servo amplifiers and drives, brushless servo, torque, and coreless motors, brush motors, integrated motor drives, gear motors, gearing, incremental and absolute optical encoders, active (electronic) and passive (magnetic) filters for power quality and harmonic issues.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.